Drug‐Induced Liver Injury by Selective Androgenic Receptor Modulators
Joan Ericka Flores, Shivakumar Chitturi, Sarah Walker
Abstract
Selective androgenic receptor modulators (SARMs) have not been approved by the U.S. Food and Drug Administration but they are heavily promoted as alternatives to androgenic anabolic steroids. We present two cases of liver injury associated with SARMs.
Topics & Concepts
DrugLiver injuryFood and drug administrationPharmacologyAnabolic-Androgenic SteroidsMedicineReceptorAnabolismInternal medicineDrug-Induced Hepatotoxicity and ProtectionHormonal and reproductive studiesPharmacogenetics and Drug Metabolism